BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17379972)

  • 21. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
    Ställberg B; Pilman E; Skoogh BE; Hermansson BA
    Respir Med; 2007 Mar; 101(3):610-5. PubMed ID: 16889952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral and inhaled corticoid therapy. Rivals or partners?].
    Lacronique J
    Rev Mal Respir; 1992; 9 Suppl 1():R69-71. PubMed ID: 1589633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral posterior subcapsular cataracts after inhaled budesonide for asthma: have patients been given their medications correctly?
    Guner SN; Kilic M; Boyraz S; Yurdakul E; Kalkan G; Ozturk F
    J Investig Allergol Clin Immunol; 2011; 21(1):80. PubMed ID: 21370732
    [No Abstract]   [Full Text] [Related]  

  • 24. Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection.
    Grünberg K; Sharon RF; Sont JK; In 't Veen JC; Van Schadewijk WA; De Klerk EP; Dick CR; Van Krieken JH; Sterk PJ
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1816-22. PubMed ID: 11734429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L; Pedersen S
    Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhaled budesonide for acute asthma--is it all a question of time and space?].
    Sarinho E
    J Pediatr (Rio J); 2004; 80(2):88-9. PubMed ID: 15079175
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined budesonide/formoterol turbuhaler treatment of asthma.
    Remington TL; Heaberlin AM; DiGiovine B
    Ann Pharmacother; 2002 Dec; 36(12):1918-28. PubMed ID: 12452756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Budesonide: efficacy and indications of low posology].
    Malo JL
    Rev Mal Respir; 1992; 9 Suppl 1():R73-7. PubMed ID: 1589634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing inhaled corticosteroid therapy in children with chronic asthma.
    O'Connell EJ
    Pediatr Pulmonol; 2005 Jan; 39(1):74-83. PubMed ID: 15532098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
    Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
    Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients.
    Essilfie-Quaye S; Ito K; Ito M; Kharitonov SA; Barnes PJ
    Respir Med; 2011 Dec; 105(12):1784-9. PubMed ID: 21903370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Metabolic Profile of Inhaled Budesonide and Salbutamol in Asthmatic Children during Acute Exacerbation.
    Quan-Jun Y; Jian-Ping Z; Jian-Hua Z; Yong-Long H; Bo X; Jing-Xian Z; Bona D; Yuan Z; Cheng G
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):303-311. PubMed ID: 27730746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity.
    Brattsand R; Miller-Larsson A
    Clin Ther; 2003; 25 Suppl C():C28-41. PubMed ID: 14642802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
    Prieto L; Gutiérrez V; Morales C
    Eur Respir J; 1999 Jun; 13(6):1236-44. PubMed ID: 10445596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new initiative to inform the patients. Education optimizes asthma therapy].
    MMW Fortschr Med; 2002 Oct; 144(41):54-5. PubMed ID: 12474365
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of budesonide inhalation suspension in the treatment of pediatric asthma.
    Szefler SJ
    Pharmacotherapy; 2001 Feb; 21(2):195-206. PubMed ID: 11213857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.
    Kharitonov SA; Donnelly LE; Montuschi P; Corradi M; Collins JV; Barnes PJ
    Thorax; 2002 Oct; 57(10):889-96. PubMed ID: 12324677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations.
    Pauwels R
    Allergy; 1998; 53(42 Suppl):20-3. PubMed ID: 9615842
    [No Abstract]   [Full Text] [Related]  

  • 39. T cells number and function in young asthmatic children during 2 years treatment with inhaled budesonide.
    Volovitz B; Shohat B; Amir J; Nussinovitch M; Varsano I
    Isr J Med Sci; 1994 Aug; 30(8):572-7. PubMed ID: 8045733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of inhaled beclometasone and budesonide. Back titration of inhaled steroids is uncommon in New Zealand.
    Black P
    BMJ; 1999 Jul; 319(7202):125; author reply 126. PubMed ID: 10465593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.